PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,191 | -54.4% | 20,154 | -42.1% | 0.00% | – |
| Q2 2023 | $456,307 | -80.3% | 34,806 | -83.2% | 0.00% | – |
| Q1 2023 | $2,317,938 | +275.5% | 207,329 | +183.2% | 0.00% | – |
| Q4 2022 | $617,236 | -77.4% | 73,219 | -55.4% | 0.00% | -100.0% |
| Q3 2022 | $2,735,000 | -29.5% | 164,178 | -37.7% | 0.00% | 0.0% |
| Q2 2022 | $3,878,000 | -12.2% | 263,471 | +48.1% | 0.00% | 0.0% |
| Q1 2022 | $4,415,000 | +13.6% | 177,953 | +46.8% | 0.00% | 0.0% |
| Q4 2021 | $3,888,000 | -77.3% | 121,221 | -74.5% | 0.00% | -66.7% |
| Q3 2021 | $17,102,000 | +44.9% | 475,311 | +77.7% | 0.00% | 0.0% |
| Q2 2021 | $11,804,000 | +31.6% | 267,544 | +36.4% | 0.00% | +50.0% |
| Q1 2021 | $8,969,000 | +0.2% | 196,086 | +51.1% | 0.00% | 0.0% |
| Q4 2020 | $8,955,000 | – | 129,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |